opened on: 3 May 2017, 23:55:18 _dta: 1. by Jean Roth , jroth@nber.org , 3 May 2017 2. NBER URL: http://www.nber.org/data/drugs-at-fda.html 3. Source Page: http://www.fda.gov/Drugs/InformationOnDrugs/ucm135821.htm 4. Source File URL: http://www.fda.gov/downloads/Drugs/InformationOnDrugs/UCM054599.zip 5. Source Text File: Product_tecode.txt > 70503.dta obs: 15,381 vars: 6 3 May 2017 23:55 size: 184,572 (_dta has notes) ------------------------------------------------------------------------------- storage display value variable name type format label variable label ------------------------------------------------------------------------------- applno long %12.0g FDA Application Number productno byte %8.0g Product Number tecodestr str3 %9s Therapeutic Equivalent (TE) Code tecode int %133.0g tecode Therapeutic Equivalence (TE) Code tesequence byte %8.0g Therapeutic Equivalent Sequence productmktstatus byte %8.0g Product Market Status ------------------------------------------------------------------------------- Sorted by: applno productno tesequence productmktstatus tecode: 1 AA = no known or suspected bioequivalence problems 2 AB = actual or potential bioequivalence problems have been resolve > d with adequate in vivo and/or in vitro evidence supporting bioequi 3 AB1 = Products meeting necessary bioequivalence requirements 4 AB1,AB2 = Products meeting necessary bioequivalence requirements 5 AB1,AB2,AB3 = Products meeting necessary bioequivalence requiremen > ts 6 AB1,AB2,AB3,AB4 = Products meeting necessary bioequivalence requir > ements 7 AB1,AB3 = Products meeting necessary bioequivalence requirements 20 AB2 = Products meeting necessary bioequivalence requirements 30 AB3 = Products meeting necessary bioequivalence requirements 40 AB4 = Products meeting necessary bioequivalence requirements 50 AN = no known or suspected bioequivalence problems 51 AO = no known or suspected bioequivalence problems 52 AP = no known or suspected bioequivalence problems 56 AT = no known or suspected bioequivalence problems 66 AT1 = no known or suspected bioequivalence problems 130 BC = actual or potential bioequivalence problems have not been re > solved by adequate evidence of bioequivalence 131 BD = actual or potential bioequivalence problems have not been re > solved by adequate evidence of bioequivalence 144 BP = actual or potential bioequivalence problems have not been re > solved by adequate evidence of bioequivalence 146 BS = actual or potential bioequivalence problems have not been re > solved by adequate evidence of bioequivalence 147 BT = actual or potential bioequivalence problems have not been re > solved by adequate evidence of bioequivalence 151 BX = actual or potential bioequivalence problems have not been re > solved by adequate evidence of bioequivalence